Two-week break from diabetes shots before endoscopy
Part of Digestive system clinical trials.
This study looks at whether stopping a type 2 diabetes medication called GLP-1 receptor agonists for two weeks before an upper endoscopy can reduce the risk of food staying in the stomach during the procedure. If you are scheduled for an upper endoscopy and take this medication, this trial may help make your procedure safer and more comfortable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for an upper endoscopy (a procedure to look inside your stomach and esophagus).
- You have complete medical records available, including your endoscopy report, age, sex, BMI, diabetes history, any prior stomach surgery, and gastrointestinal symptoms.
- You do not have cancer or blockage in your upper digestive tract.
- You have not had any stomach surgery before (including procedures like endoscopic submucosal dissection, gastrectomy, or gastric bypass).
- Your endoscopy is elective, not an emergency procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether stopping semaglutide for one week before a sedated endoscopy improves how well the stomach is seen and how quickly it empties. It may help doctors better understand how this medicine affects the procedure.
This study looks at whether nerve damage from diabetes affects how long semaglutide (a diabetes medicine) stays in the stomach, which can cause stomach retention. It may help doctors understand who is more likely to have this side effect.
This study uses an ultrasound to look at how full your stomach is after taking GLP-1 medications for diabetes or weight loss. It will help doctors understand if current fasting guidelines are safe before surgery or a colonoscopy.
This trial is testing whether stopping GLP-1 receptor agonists or tirzepatide one week before an upper endoscopy (a scope that looks at your stomach and esophagus) is safe and effective. It's designed for people who are already taking these medications and have an upcoming procedure.
This study looks at whether stopping GLP-1 receptor agonists (a type of diabetes or weight-loss medication) before a colonoscopy can help improve the procedure. It compares how well the bowel is cleaned in people who stop these drugs for a certain time versus those who continue them.
This study tests whether drinking only clear liquids before an upper endoscopy can reduce leftover stomach contents in people taking GLP-1 medications (like Ozempic or Mounjaro). It may help make the procedure safer.
Hear when a new Gastric Retention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.